Farmakogenetik og skraeddersyet medicinsk behandling

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Farmakogenetik og skraeddersyet medicinsk behandling. / Nielsen, Finn Cilius; Borregaard, Niels.

In: Ugeskrift for læger, Vol. 171, No. 10, 2009, p. 790-4.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Nielsen, FC & Borregaard, N 2009, 'Farmakogenetik og skraeddersyet medicinsk behandling', Ugeskrift for læger, vol. 171, no. 10, pp. 790-4.

APA

Nielsen, F. C., & Borregaard, N. (2009). Farmakogenetik og skraeddersyet medicinsk behandling. Ugeskrift for læger, 171(10), 790-4.

Vancouver

Nielsen FC, Borregaard N. Farmakogenetik og skraeddersyet medicinsk behandling. Ugeskrift for læger. 2009;171(10):790-4.

Author

Nielsen, Finn Cilius ; Borregaard, Niels. / Farmakogenetik og skraeddersyet medicinsk behandling. In: Ugeskrift for læger. 2009 ; Vol. 171, No. 10. pp. 790-4.

Bibtex

@article{63d2f59009b311df825d000ea68e967b,
title = "Farmakogenetik og skraeddersyet medicinsk behandling",
abstract = "Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2",
author = "Nielsen, {Finn Cilius} and Niels Borregaard",
note = "Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines",
year = "2009",
language = "Dansk",
volume = "171",
pages = "790--4",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "10",

}

RIS

TY - JOUR

T1 - Farmakogenetik og skraeddersyet medicinsk behandling

AU - Nielsen, Finn Cilius

AU - Borregaard, Niels

N1 - Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines

PY - 2009

Y1 - 2009

N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2

AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2

M3 - Tidsskriftartikel

C2 - 19265602

VL - 171

SP - 790

EP - 794

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 10

ER -

ID: 17215571